ArticleCureus2025
Severe Anemia With Intraosseous-Intramuscular Hemorrhage in a Patient With Kit-C-Negative Systemic Mastocytosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic mastocytosis (SM) is a rare hematologic disorder characterized by clonal proliferation of mast cells in various tissues, often presenting with skin lesions, gastrointestinal symptoms, or anaphylaxis. However, atypical presentations lacking these classical features may delay diagnosis and complicate management. We report the case of a 42-year-old woman who presented with progressive anemia, recurrent spontaneous intramuscular and intraosseous hemorrhages, and severe, unexplained pain. Notably, she lacked cutaneous signs or known allergic triggers. Extensive laboratory and imaging workups ruled out common hematologic and autoimmune causes. Bone marrow biopsy ultimately revealed multifocal clusters of atypical mast cells consistent with SM, despite the absence of the KIT D816V mutation. This case underscores the protean manifestations of SM and the need to maintain a high index of suspicion in patients with unexplained cytopenia and bleeding. It also highlights the role of bone marrow evaluation in the diagnostic pathway, even when classic clinical features are absent. Timely recognition of atypical SM can guide appropriate management and improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.